The Clorox Company
CLX · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $7,104 | $7,093 | $7,389 | $7,107 |
| % Growth | 0.2% | -4% | 4% | – |
| Cost of Goods Sold | $3,910 | $4,068 | $4,518 | $4,616 |
| Gross Profit | $3,194 | $3,025 | $2,871 | $2,491 |
| % Margin | 45% | 42.6% | 38.9% | 35% |
| R&D Expenses | $121 | $126 | $138 | $132 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,894 | $1,983 | $1,905 | $1,663 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,015 | $2,109 | $2,044 | $1,795 |
| Operating Income | $1,179 | $916 | $827 | $696 |
| % Margin | 16.6% | 12.9% | 11.2% | 9.8% |
| Other Income/Exp. Net | -$101 | -$518 | -$589 | -$89 |
| Pre-Tax Income | $1,078 | $398 | $238 | $607 |
| Tax Expense | $254 | $106 | $77 | $136 |
| Net Income | $810 | $280 | $149 | $462 |
| % Margin | 11.4% | 3.9% | 2% | 6.5% |
| EPS | 6.56 | 2.25 | 1.21 | 3.75 |
| % Growth | 191.6% | 86% | -67.7% | – |
| EPS Diluted | 6.52 | 2.25 | 1.2 | 3.73 |
| Weighted Avg Shares Out | 124 | 124 | 124 | 123 |
| Weighted Avg Shares Out Dil | 124 | 125 | 124 | 124 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $23 | $16 | $5 |
| Interest Expense | $101 | $103 | $103 | $97 |
| Depreciation & Amortization | $219 | $235 | $236 | $224 |
| EBITDA | $1,398 | $736 | $577 | $928 |
| % Margin | 19.7% | 10.4% | 7.8% | 13.1% |